Evidence map›Paper›PMID 39360992›Full record

ArticleBioinformatics (Oxford, England)2024

Castanet: a pipeline for rapid analysis of targeted multi-pathogen genomic data.

Richard Mayne, Shannah Secret, Cyndi Geoghegan, Amy Trebes, Kai Kean, Kaitlin Reid, Gu-Lung Lin, M Azim Ansari, Mariateresa de Cesare, David Bonsall and 10 more

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Richard MayneNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.ORCID 0000-0003-1915-4993
Shannah SecretRadcliffe Department of Medicine, University of Oxford, West Wing John Radcliffe Hospital, Oxfordshire OX3 9DU, United Kingdom.
Cyndi GeogheganCentre for Human Genetics, University of Oxford, Oxfordshire OX3 7BN, United Kingdom.
Amy TrebesGenewiz UK Ltd, Azenta Life Sciences, Oxfordshire OX14 1SG, United Kingdom.
Kai KeanNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
Kaitlin ReidNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
Gu-Lung LinOxford Vaccine Group, University of Oxford, Oxfordshire OX3 7LE, United Kingdom.
M Azim AnsariNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
Mariateresa de CesareNational Facility for Genomics, Human Technopole, Viale Rita Levi-Montalcini, Milan 20157, Italy.
David BonsallNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
Ivo ElliottCentre for Tropical Medicine and Global Health, University of Oxford, Oxfordshire OX3 7LE, United Kingdom.
Paolo PiazzaCentre for Human Genetics, University of Oxford, Oxfordshire OX3 7BN, United Kingdom.
Anthony BrownNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
James BrayDepartment of Biology, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.
Julian C KnightOxford Genomics Centre, University of Oxford, Oxfordshire OX3 7BN, United Kingdom.ORCID 0000-0002-0377-5536
Heli HarvalaRadcliffe Department of Medicine, University of Oxford, West Wing John Radcliffe Hospital, Oxfordshire OX3 9DU, United Kingdom.
Judith BreuerInstitute of Child Health, University College London, London WC1N 1EH, United Kingdom.
Peter SimmondsNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.ORCID 0000-0002-7964-4700
Rory J BowdenGenomics Lab, The Walter and Eliza Hall Institute of Medical Research, Victoria 3052, Melbourne, Australia.
Tanya GolubchikNuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxfordshire OX1 3SY, United Kingdom.ORCID 0000-0003-2765-9828

Funding

UK National Institutes for Health Research NIHR203338
6 · The paper itself

Abstract

motivationTarget enrichment strategies generate genomic data from multiple pathogens in a single process, greatly improving sensitivity over metagenomic sequencing and enabling cost-effective, high-throughput surveillance and clinical applications. However, uptake by research and clinical laboratories is constrained by an absence of computational tools that are specifically designed for the analysis of multi-pathogen enrichment sequence data. Here we present an analysis pipeline, Castanet, for use with multi-pathogen enrichment sequencing data. Castanet is designed to work with short-read data produced by existing targeted enrichment strategies, but can be readily deployed on any BAM file generated by another methodology. Also included are an optional graphical interface and installer script.

resultsIn addition to genome reconstruction, Castanet reports method-specific metrics that enable quantification of capture efficiency, estimation of pathogen load, differentiation of low-level positives from contamination, and assessment of sequencing quality. Castanet can be used as a traditional end-to-end pipeline for consensus generation, but its strength lies in the ability to process a flexible, pre-defined set of pathogens of interest directly from multi-pathogen enrichment experiments. In our tests, Castanet consensus sequences were accurate reconstructions of reference sequences, including in instances where multiple strains of the same pathogen were present. Castanet performs effectively on standard computers and can process the entire output of a 96-sample enrichment sequencing run (50M reads) using a single batch process command, in $<$2 h. AVAILABILITY AND IMPLEMENTATION: Source code freely available under GPL-3 license at https://github.com/MultipathogenGenomics/castanet, implemented in Python 3.10 and supported in Ubuntu Linux 22.04. The data underlying this article are available in Europe Nucleotide Archives, at https://www.ebi.ac.uk/ena/browser/view/PRJEB77004.

Indexed as

SoftwareGenomicsHigh-Throughput Nucleotide SequencingHumansMetagenomicsSequence Analysis, DNA

Identifiers

PMID39360992
PMCPMC11494375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.